COMP <GO>
ORKA vs LNTH // EV/EBITDA & P/E VALUATION
Oruka Therapeutics Inc. (NASDAQ) VS. Lantheus Holdings Inc. (NASDAQ) • 15-METRIC TALLY: ORKA 3
— LNTH 8
■ METRIC PARITY
LAST: $95.43 (-1.49%) • MKT CAP: $6.41B
valuation
—
LAST: $100.31 (-0.15%) • MKT CAP: $6.56B
valuation
18.0x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ORKA VS. LNTH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ORKA | LNTH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 61.10% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -18.80% | 20.30% | -39.10 | LNTH | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 18.0x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.38% | 4.90% | -6.28 | LNTH | /fcf-yield <GO> |
| Operating Margin | -6.80% | 20.20% | -27.00 | LNTH | /operating-margins <GO> |
| Net Profit Margin | -5.90% | 15.20% | -21.10 | LNTH | /net-margins <GO> |
| Revenue Growth (YoY) | -4.40% | 0.50% | -4.90 | LNTH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 5.34 | +20.66 | ORKA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | LNTH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 67.0 | 55.8 | +11.20 | ORKA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.13 | 0.88 | +0.25 | ORKA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 28.0x | 26.0x | +2.00 | LNTH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.41B | $6.56B | -$143.5M | LNTH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ORKA REV | LNTH REV | ORKA GROSS % | LNTH GROSS % | ORKA FCF | LNTH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $341.7M | $1.54B | — | 61.1% | -$88.4M | $320.8M |
| FY 2024 | $246.7M | $1.53B | — | 64.4% | -$58.0M | $475.7M |
| FY 2023 | $20.4M | $1.30B | — | — | -$5.0M | $246.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ORKA // BETA 1.13
LNTH // BETA 0.88